• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by The Carlyle Group Inc. (Amendment)

    2/12/24 5:45:02 PM ET
    $CG
    Investment Managers
    Finance
    Get the next $CG alert in real time by email
    SC 13G/A 1 d792127dsc13ga.htm SC 13G/A SC 13G/A

     

     

    Securities and Exchange Commission

    Washington, D.C. 20549

     

     

    Schedule 13G

    (Rule 13d-102)

    Information to be Included in Statements Filed Pursuant

    to § 240.13d-1(b), (c) and (d) and Amendments Thereto Filed

    Pursuant to § 240.13d-2

    UNDER THE SECURITIES EXCHANGE ACT OF 1934

    (Amendment No. 1)*

     

     

    MKS Instruments, Inc.

    (Name of Issuer)

    Common Stock, no par value

    (Title of Class of Securities)

    55306N104

    (CUSIP Number)

    December 31, 2023

    (Date of Event Which Requires Filing of this Statement)

     

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

    ☐ Rule 13d-1(b)

    ☒ Rule 13d-1(c)

    ☐ Rule 13d-1(d)

     

    *

    The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     


    CUSIP No. 55306N104   Schedule 13G   Page 1 of 25

     

     1   

     Names of Reporting Persons

     

     The Carlyle Group Inc.

     2  

     Check the Appropriate Box if a Member of a Group

     

     (a) ☐  (b) ☐

     3  

     SEC Use Only

     

     4  

     Citizenship or Place of Organization

     

     Delaware

    Number of

    Shares  Beneficially 

    Owned by

    Each

    Reporting

    Person

    With

       5   

     Sole Voting Power

     

     0

       6  

     Shared Voting Power

     

     0

       7  

     Sole Dispositive Power

     

     0

       8  

     Shared Dispositive Power

     

     0

     9   

     Aggregate Amount Beneficially Owned by Each Reporting Person

     

     0

    10  

     Check if the Aggregate Amount in Row (9) Excludes Certain Shares

     

     Not Applicable

    11  

     Percent of Class Represented by Amount in Row 9

     

     0.0%

    12  

     Type of Reporting Person

     

     CO


    CUSIP No. 55306N104   Schedule 13G   Page 2 of 25

     

     1   

     Names of Reporting Persons

     

     Carlyle Holdings II GP L.L.C.

     2  

     Check the Appropriate Box if a Member of a Group

     

     (a) ☐  (b) ☐

     3  

     SEC Use Only

     

     4  

     Citizenship or Place of Organization

     

     Delaware

    Number of

    Shares  Beneficially 

    Owned by

    Each

    Reporting

    Person

    With

       5   

     Sole Voting Power

     

     0

       6  

     Shared Voting Power

     

     0

       7  

     Sole Dispositive Power

     

     0

       8  

     Shared Dispositive Power

     

     0

     9   

     Aggregate Amount Beneficially Owned by Each Reporting Person

     

     0

    10  

     Check if the Aggregate Amount in Row (9) Excludes Certain Shares

     

     Not Applicable

    11  

     Percent of Class Represented by Amount in Row 9

     

     0.0%

    12  

     Type of Reporting Person

     

     OO (Limited Liability Company)


    CUSIP No. 55306N104   Schedule 13G   Page 3 of 25

     

     1   

     Names of Reporting Persons

     

     Carlyle Holdings II L.L.C.

     2  

     Check the Appropriate Box if a Member of a Group

     

     (a) ☐  (b) ☐

     3  

     SEC Use Only

     

     4  

     Citizenship or Place of Organization

     

     Delaware

    Number of

    Shares  Beneficially 

    Owned by

    Each

    Reporting

    Person

    With

       5   

     Sole Voting Power

     

     0

       6  

     Shared Voting Power

     

     0

       7  

     Sole Dispositive Power

     

     0

       8  

     Shared Dispositive Power

     

     0

     9   

     Aggregate Amount Beneficially Owned by Each Reporting Person

     

     0

    10  

     Check if the Aggregate Amount in Row (9) Excludes Certain Shares

     

     Not Applicable

    11  

     Percent of Class Represented by Amount in Row 9

     

     0.0%

    12  

     Type of Reporting Person

     

     OO (Limited Liability Company)


    CUSIP No. 55306N104   Schedule 13G   Page 4 of 25

     

     1   

     Names of Reporting Persons

     

     CG Subsidiary Holdings L.L.C.

     2  

     Check the Appropriate Box if a Member of a Group

     

     (a) ☐  (b) ☐

     3  

     SEC Use Only

     

     4  

     Citizenship or Place of Organization

     

     Delaware

    Number of

    Shares  Beneficially 

    Owned by

    Each

    Reporting

    Person

    With

       5   

     Sole Voting Power

     

     0

       6  

     Shared Voting Power

     

     0

       7  

     Sole Dispositive Power

     

     0

       8  

     Shared Dispositive Power

     

     0

     9   

     Aggregate Amount Beneficially Owned by Each Reporting Person

     

     0

    10  

     Check if the Aggregate Amount in Row (9) Excludes Certain Shares

     

     Not Applicable

    11  

     Percent of Class Represented by Amount in Row 9

     

     0.0%

    12  

     Type of Reporting Person

     

     OO (Limited Liability Company)


    CUSIP No. 55306N104   Schedule 13G   Page 5 of 25

     

     1   

     Names of Reporting Persons

     

     TC Group Cayman Investment Holdings, L.P.

     2  

     Check the Appropriate Box if a Member of a Group

     

     (a) ☐  (b) ☐

     3  

     SEC Use Only

     

     4  

     Citizenship or Place of Organization

     

     Cayman Islands

    Number of

    Shares  Beneficially 

    Owned by

    Each

    Reporting

    Person

    With

       5   

     Sole Voting Power

     

     0

       6  

     Shared Voting Power

     

     0

       7  

     Sole Dispositive Power

     

     0

       8  

     Shared Dispositive Power

     

     0

     9   

     Aggregate Amount Beneficially Owned by Each Reporting Person

     

     0

    10  

     Check if the Aggregate Amount in Row (9) Excludes Certain Shares

     

     Not Applicable

    11  

     Percent of Class Represented by Amount in Row 9

     

     0.0%

    12  

     Type of Reporting Person

     

     PN


    CUSIP No. 55306N104   Schedule 13G   Page 6 of 25

     

     1   

     Names of Reporting Persons

     

     TC Group Cayman Investment Holdings Sub L.P.

     2  

     Check the Appropriate Box if a Member of a Group

     

     (a) ☐  (b) ☐

     3  

     SEC Use Only

     

     4  

     Citizenship or Place of Organization

     

     Cayman Islands

    Number of

    Shares  Beneficially 

    Owned by

    Each

    Reporting

    Person

    With

       5   

     Sole Voting Power

     

     0

       6  

     Shared Voting Power

     

     0

       7  

     Sole Dispositive Power

     

     0

       8  

     Shared Dispositive Power

     

     0

     9   

     Aggregate Amount Beneficially Owned by Each Reporting Person

     

     0

    10  

     Check if the Aggregate Amount in Row (9) Excludes Certain Shares

     

     Not Applicable

    11  

     Percent of Class Represented by Amount in Row 9

     

     0.0%

    12  

     Type of Reporting Person

     

     PN


    CUSIP No. 55306N104   Schedule 13G   Page 7 of 25

     

     1   

     Names of Reporting Persons

     

     TC Group VI Cayman, L.L.C.

     2  

     Check the Appropriate Box if a Member of a Group

     

     (a) ☐  (b) ☐

     3  

     SEC Use Only

     

     4  

     Citizenship or Place of Organization

     

     Delaware

    Number of

    Shares  Beneficially 

    Owned by

    Each

    Reporting

    Person

    With

       5   

     Sole Voting Power

     

     0

       6  

     Shared Voting Power

     

     0

       7  

     Sole Dispositive Power

     

     0

       8  

     Shared Dispositive Power

     

     0

     9   

     Aggregate Amount Beneficially Owned by Each Reporting Person

     

     0

    10  

     Check if the Aggregate Amount in Row (9) Excludes Certain Shares

     

     Not Applicable

    11  

     Percent of Class Represented by Amount in Row 9

     

     0.0%

    12  

     Type of Reporting Person

     

     OO (Limited Liability Company)


    CUSIP No. 55306N104   Schedule 13G   Page 8 of 25

     

     1   

     Names of Reporting Persons

     

     TC Group VI Cayman, L.P.

     2  

     Check the Appropriate Box if a Member of a Group

     

     (a) ☐  (b) ☐

     3  

     SEC Use Only

     

     4  

     Citizenship or Place of Organization

     

     Cayman Islands

    Number of

    Shares  Beneficially 

    Owned by

    Each

    Reporting

    Person

    With

       5   

     Sole Voting Power

     

     0

       6  

     Shared Voting Power

     

     0

       7  

     Sole Dispositive Power

     

     0

       8  

     Shared Dispositive Power

     

     0

     9   

     Aggregate Amount Beneficially Owned by Each Reporting Person

     

     0

    10  

     Check if the Aggregate Amount in Row (9) Excludes Certain Shares

     

     Not Applicable

    11  

     Percent of Class Represented by Amount in Row 9

     

     0.0%

    12  

     Type of Reporting Person

     

     PN


    CUSIP No. 55306N104   Schedule 13G   Page 9 of 25

     

     1   

     Names of Reporting Persons

     

     Carlyle Partners VI Cayman Holdings, L.P.

     2  

     Check the Appropriate Box if a Member of a Group

     

     (a) ☐  (b) ☐

     3  

     SEC Use Only

     

     4  

     Citizenship or Place of Organization

     

     Cayman Islands

    Number of

    Shares  Beneficially 

    Owned by

    Each

    Reporting

    Person

    With

       5   

     Sole Voting Power

     

     0

       6  

     Shared Voting Power

     

     0

       7  

     Sole Dispositive Power

     

     0

       8  

     Shared Dispositive Power

     

     0

     9   

     Aggregate Amount Beneficially Owned by Each Reporting Person

     

     0

    10  

     Check if the Aggregate Amount in Row (9) Excludes Certain Shares

     

     Not Applicable

    11  

     Percent of Class Represented by Amount in Row 9

     

     0.0%

    12  

     Type of Reporting Person

     

     PN


    CUSIP No. 55306N104   Schedule 13G   Page 10 of 25

     

     1   

     Names of Reporting Persons

     

     CEP IV Managing GP Holdings, Ltd.

     2  

     Check the Appropriate Box if a Member of a Group

     

     (a) ☐  (b) ☐

     3  

     SEC Use Only

     

     4  

     Citizenship or Place of Organization

     

     Cayman Islands

    Number of

    Shares  Beneficially 

    Owned by

    Each

    Reporting

    Person

    With

       5   

     Sole Voting Power

     

     0

       6  

     Shared Voting Power

     

     0

       7  

     Sole Dispositive Power

     

     0

       8  

     Shared Dispositive Power

     

     0

     9   

     Aggregate Amount Beneficially Owned by Each Reporting Person

     

     0

    10  

     Check if the Aggregate Amount in Row (9) Excludes Certain Shares

     

     Not Applicable

    11  

     Percent of Class Represented by Amount in Row 9

     

     0.0%

    12  

     Type of Reporting Person

     

     CO


    CUSIP No. 55306N104   Schedule 13G   Page 11 of 25

     

     1   

     Names of Reporting Persons

     

     CEP IV Managing GP, L.P.

     2  

     Check the Appropriate Box if a Member of a Group

     

     (a) ☐  (b) ☐

     3  

     SEC Use Only

     

     4  

     Citizenship or Place of Organization

     

     Scotland

    Number of

    Shares  Beneficially 

    Owned by

    Each

    Reporting

    Person

    With

       5   

     Sole Voting Power

     

     0

       6  

     Shared Voting Power

     

     0

       7  

     Sole Dispositive Power

     

     0

       8  

     Shared Dispositive Power

     

     0

     9   

     Aggregate Amount Beneficially Owned by Each Reporting Person

     

     0

    10  

     Check if the Aggregate Amount in Row (9) Excludes Certain Shares

     

     Not Applicable

    11  

     Percent of Class Represented by Amount in Row 9

     

     0.0%

    12  

     Type of Reporting Person

     

     PN


    CUSIP No. 55306N104   Schedule 13G   Page 12 of 25

     

     1   

     Names of Reporting Persons

     

     Carlyle Europe Partners IV, L.P.

     2  

     Check the Appropriate Box if a Member of a Group

     

     (a) ☐  (b) ☐

     3  

     SEC Use Only

     

     4  

     Citizenship or Place of Organization

     

     England and Wales

    Number of

    Shares  Beneficially 

    Owned by

    Each

    Reporting

    Person

    With

       5   

     Sole Voting Power

     

     0

       6  

     Shared Voting Power

     

     0

       7  

     Sole Dispositive Power

     

     0

       8  

     Shared Dispositive Power

     

     0

     9   

     Aggregate Amount Beneficially Owned by Each Reporting Person

     

     0

    10  

     Check if the Aggregate Amount in Row (9) Excludes Certain Shares

     

     Not Applicable

    11  

     Percent of Class Represented by Amount in Row 9

     

     0.0%

    12  

     Type of Reporting Person

     

     PN


    CUSIP No. 55306N104   Schedule 13G   Page 13 of 25

     

     1   

     Names of Reporting Persons

     

     CEP IV Participations, S.à r.l. SICAR

     2  

     Check the Appropriate Box if a Member of a Group

     

     (a) ☐  (b) ☐

     3  

     SEC Use Only

     

     4  

     Citizenship or Place of Organization

     

     Luxembourg

    Number of

    Shares  Beneficially 

    Owned by

    Each

    Reporting

    Person

    With

       5   

     Sole Voting Power

     

     0

       6  

     Shared Voting Power

     

     0

       7  

     Sole Dispositive Power

     

     0

       8  

     Shared Dispositive Power

     

     0

     9   

     Aggregate Amount Beneficially Owned by Each Reporting Person

     

     0

    10  

     Check if the Aggregate Amount in Row (9) Excludes Certain Shares

     

     Not Applicable

    11  

     Percent of Class Represented by Amount in Row 9

     

     0.0%

    12  

     Type of Reporting Person

     

     OO (Luxembourg Limited Liability Company)


    CUSIP No. 55306N104   Schedule 13G   Page 14 of 25

     

     1   

     Names of Reporting Persons

     

     CAP IV, L.L.C.

     2  

     Check the Appropriate Box if a Member of a Group

     

     (a) ☐  (b) ☐

     3  

     SEC Use Only

     

     4  

     Citizenship or Place of Organization

     

     Delaware

    Number of

    Shares  Beneficially 

    Owned by

    Each

    Reporting

    Person

    With

       5   

     Sole Voting Power

     

     0

       6  

     Shared Voting Power

     

     0

       7  

     Sole Dispositive Power

     

     0

       8  

     Shared Dispositive Power

     

     0

     9   

     Aggregate Amount Beneficially Owned by Each Reporting Person

     

     0

    10  

     Check if the Aggregate Amount in Row (9) Excludes Certain Shares

     

     Not Applicable

    11  

     Percent of Class Represented by Amount in Row 9

     

     0.0%

    12  

     Type of Reporting Person

     

     OO (Limited Liability Company)


    CUSIP No. 55306N104   Schedule 13G   Page 15 of 25

     

     1   

     Names of Reporting Persons

     

     CAP IV General Partner, L.P.

     2  

     Check the Appropriate Box if a Member of a Group

     

     (a) ☐  (b) ☐

     3  

     SEC Use Only

     

     4  

     Citizenship or Place of Organization

     

     Cayman Islands

    Number of

    Shares  Beneficially 

    Owned by

    Each

    Reporting

    Person

    With

       5   

     Sole Voting Power

     

     0

       6  

     Shared Voting Power

     

     0

       7  

     Sole Dispositive Power

     

     0

       8  

     Shared Dispositive Power

     

     0

     9   

     Aggregate Amount Beneficially Owned by Each Reporting Person

     

     0

    10  

     Check if the Aggregate Amount in Row (9) Excludes Certain Shares

     

     Not Applicable

    11  

     Percent of Class Represented by Amount in Row 9

     

     0.0%

    12  

     Type of Reporting Person

     

     PN


    CUSIP No. 55306N104   Schedule 13G   Page 16 of 25

     

     1   

     Names of Reporting Persons

     

     Carlyle Asia Partners IV, L.P.

     2  

     Check the Appropriate Box if a Member of a Group

     

     (a) ☐  (b) ☐

     3  

     SEC Use Only

     

     4  

     Citizenship or Place of Organization

     

     Cayman Islands

    Number of

    Shares  Beneficially 

    Owned by

    Each

    Reporting

    Person

    With

       5   

     Sole Voting Power

     

     0

       6  

     Shared Voting Power

     

     0

       7  

     Sole Dispositive Power

     

     0

       8  

     Shared Dispositive Power

     

     0

     9   

     Aggregate Amount Beneficially Owned by Each Reporting Person

     

     0

    10  

     Check if the Aggregate Amount in Row (9) Excludes Certain Shares

     

     Not Applicable

    11  

     Percent of Class Represented by Amount in Row 9

     

     0.0%

    12  

     Type of Reporting Person

     

     PN


    CUSIP No. 55306N104   Schedule 13G   Page 17 of 25

     

     1   

     Names of Reporting Persons

     

     Gamma Holding Company Limited

     2  

     Check the Appropriate Box if a Member of a Group

     

     (a) ☐  (b) ☐

     3  

     SEC Use Only

     

     4  

     Citizenship or Place of Organization

     

     Cayman Islands

    Number of

    Shares  Beneficially 

    Owned by

    Each

    Reporting

    Person

    With

       5   

     Sole Voting Power

     

     0

       6  

     Shared Voting Power

     

     0

       7  

     Sole Dispositive Power

     

     0

       8  

     Shared Dispositive Power

     

     0

     9   

     Aggregate Amount Beneficially Owned by Each Reporting Person

     

     0

    10  

     Check if the Aggregate Amount in Row (9) Excludes Certain Shares

     

     Not Applicable

    11  

     Percent of Class Represented by Amount in Row 9

     

     0.0%

    12  

     Type of Reporting Person

     

     CO


    CUSIP No. 55306N104   Schedule 13G   Page 18 of 25

     

    ITEM 1.

    (a) Name of Issuer:

    MKS Instruments, Inc. (the “Issuer”)

    (b) Address of Issuer’s Principal Executive Offices:

    2 Tech Drive, Suite 201, Andover, Massachusetts 01810

     

    ITEM 2.

    (a) Name of Person Filing:

    Each of the following is hereinafter individually referred to as a “Reporting Person” and collectively as the “Reporting Persons.” This statement is filed on behalf of:

    The Carlyle Group Inc.

    Carlyle Holdings II GP L.L.C.

    Carlyle Holdings II L.L.C.

    CG Subsidiary Holdings L.L.C.

    TC Group Cayman Investment Holdings, L.P.

    TC Group Cayman Investment Holdings Sub L.P.

    TC Group VI Cayman, L.L.C.

    TC Group VI Cayman, L.P.

    Carlyle Partners VI Cayman Holdings, L.P.

    CEP IV Managing GP Holdings, Ltd.

    CEP IV Managing GP, L.P.

    Carlyle Europe Partners IV, L.P.

    CEP IV Participations, S.à r.l. SICAR

    CAP IV, L.L.C.

    CAP IV General Partner, L.P.

    Carlyle Asia Partners IV, L.P.

    Gamma Holding Company Limited

    (b) Address or Principal Business Office:

    The address for each of TC Group Cayman Investment Holdings, L.P., TC Group Cayman Investment Holdings Sub L.P., TC Group VI Cayman, L.P., Carlyle Partners VI Cayman Holdings, L.P., CEP IV Managing GP Holdings, Ltd., CAP IV General Partner, L.P., Carlyle Asia Partners IV, L.P. and Gamma Holding Company Limited is c/o Walkers, 190 Elgin Avenue, George Town, Grand Cayman KY1-9001, Cayman Islands. The address for CEP IV Participations, S.à r.l. SICAR is c/o The Carlyle Group, 2, avenue Charles de Gaulle, L-1653 Luxembourg, Luxembourg. The address for each of the remaining Reporting Persons is c/o The Carlyle Group Inc., 1001 Pennsylvania Avenue NW, Suite 220 South, Washington, D.C. 20004-2505.


    CUSIP No. 55306N104   Schedule 13G   Page 19 of 25

     

    (c) Citizenship of each Reporting Person is:

    Each of TC Group Cayman Investment Holdings, L.P., TC Group Cayman Investment Holdings Sub L.P., TC Group VI Cayman, L.P., Carlyle Partners VI Cayman Holdings, L.P., CEP IV Managing GP Holdings, Ltd., CAP IV General Partner, L.P., Carlyle Asia Partners IV, L.P. and Gamma Holding Company Limited is organized under the laws of the Cayman Islands. Carlyle Europe Partners IV, L.P. is organized under the laws of England and Wales. CEP IV Managing GP, L.P. is organized under the laws of Scotland. CEP IV Participations, S.à r.l. SICAR is organized under the laws of Luxembourg. Each of the remaining Reporting Persons is organized under the laws of the State of Delaware.

    (d) Title of Class of Securities:

    Common Stock, no par value (“Common Stock”).

    (e) CUSIP Number:

    55306N104

     

    ITEM 3.

    Not applicable.


    CUSIP No. 55306N104   Schedule 13G   Page 20 of 25

     

    ITEM 4.

    Ownership.

    (a-c)

    This amendment to Schedule 13G is being filed to report that, as of the date hereof, the Reporting Persons do not beneficially own any shares of Common Stock.

     

    ITEM 5.

    Ownership of Five Percent or Less of a Class.

    If this statement is being filed to report the fact that as of the date hereof the Reporting Persons have ceased to be the beneficial owners of more than five percent of the class of securities, check the following: ☒

     

    ITEM 6.

    Ownership of More than Five Percent on Behalf of Another Person.

    Not applicable.

     

    ITEM 7.

    Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company.

    Not applicable.

     

    ITEM 8.

    Identification and Classification of Members of the Group.

    Not applicable.

     

    ITEM 9.

    Notice of Dissolution of Group.

    Not applicable.

     

    ITEM 10.

    Certification.

    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.


    CUSIP No. 55306N104   Schedule 13G   Page 21 of 25

     

    SIGNATURE

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

    Date: February 12, 2024

     

    The Carlyle Group Inc.
    By:  

    /s/ Anne Frederick, attorney-in-fact

    Name:   John C. Redett
    Title:   Chief Financial Officer
    Carlyle Holdings II GP L.L.C.
    By:   The Carlyle Group Inc., its sole member
    By:  

    /s/ Anne Frederick, attorney-in-fact

    Name:   John C. Redett
    Title:   Chief Financial Officer
    Carlyle Holdings II L.L.C.
    By:  

    /s/ Anne Frederick, attorney-in-fact

    Name:   John C. Redett
    Title:   Managing Director
    CG Subsidiary Holdings L.L.C.
    By:  

    /s/ Anne Frederick, attorney-in-fact

    Name:   John C. Redett
    Title:   Managing Director
    TC Group Cayman Investment Holdings, L.P.
    By: CG Subsidiary Holdings L.L.C., its general partner
    By:  

    /s/ Anne Frederick, attorney-in-fact

    Name:   John C. Redett
    Title:   Managing Director


    CUSIP No. 55306N104   Schedule 13G   Page 22 of 25

     

     

     

    TC Group Cayman Investment Holdings Sub L.P.
    By: TC Group Cayman Investment Holdings, L.P., its general partner
    By: CG Subsidiary Holdings L.L.C., its general partner
    By:  

    /s/ Anne Frederick, attorney-in-fact

    Name:   John C. Redett
    Title:   Managing Director
    TC Group VI Cayman, L.L.C.
    By:  

    /s/ Jeremy W. Anderson

    Name:   Jeremy W. Anderson
    Title:   Vice President
    TC Group VI Cayman, L.P.
    By:   TC Group VI Cayman, L.L.C., its general partner
    By:  

    /s/ Jeremy W. Anderson

    Name:   Jeremy W. Anderson
    Title:   Vice President
    Carlyle Partners VI Cayman Holdings, L.P.
    By:   TC Group VI Cayman, L.P., its general partner
    By:   TC Group VI Cayman, L.L.C., its general partner
    By:  

    /s/ Jeremy W. Anderson

    Name:   Jeremy W. Anderson
    Title:   Vice President
    CEP IV Managing GP Holdings, Ltd.
    By:  

    /s/ Jeremy W. Anderson

    Name:   Jeremy W. Anderson
    Title:   Director


    CUSIP No. 55306N104   Schedule 13G   Page 23 of 25

     

    CEP IV Managing GP, L.P.
    By:   CEP IV Managing GP Holdings, Ltd., its general partner
    By:  

    /s/ Jeremy W. Anderson

    Name:   Jeremy W. Anderson
    Title:   Director
    Carlyle Europe Partners IV, L.P.
    By: CEP IV Managing GP, L.P., its general partner
    By: CEP IV Managing GP Holdings, Ltd., its general partner
    By:  

    /s/ Jeremy W. Anderson

    Name:   Jeremy W. Anderson
    Title:   Director
    CEP IV Participations, S.à r.l. SICAR
    Represented by Christelle Frank, and William Cagney, as Managers
    By:  

    /s/ Christelle Frank

    Name:   Christelle Frank
    By:  

    /s/ William Cagney

    Name:   William Cagney
    CAP IV, L.L.C.
    By:  

    /s/ Jeremy W. Anderson

    Name:   Jeremy W. Anderson
    Title:   Vice President
    CAP IV General Partner, L.P.
    By:   CAP IV, L.L.C., its general partner
    By:  

    /s/ Jeremy W. Anderson

    Name:   Jeremy W. Anderson
    Title:   Vice President


    CUSIP No. 55306N104   Schedule 13G   Page 24 of 25

     

    Carlyle Asia Partners IV, L.P.
    By: CAP IV General Partner, L.P., its general partner
    By: CAP IV, L.L.C., its general partner
    By:  

    /s/ Jeremy W. Anderson

    Name:   Jeremy W. Anderson
    Title:   Vice President
    Gamma Holding Company Limited
    By:  

    /s/ Anat Holtzman

    Name:   Anat Holtzman
    Title:   Director


    CUSIP No. 55306N104   Schedule 13G   Page 25 of 25

     

    LIST OF EXHIBITS

     

    Exhibit No.

      

    Description

    24    Power of Attorney.
    99    Joint Filing Agreement (previously filed).
    Get the next $CG alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CG

    DatePrice TargetRatingAnalyst
    12/11/2025$74.00Buy
    UBS
    10/3/2025$74.00Outperform
    BMO Capital Markets
    7/10/2025$65.00Neutral → Buy
    Citigroup
    5/14/2025$56.00Hold → Buy
    TD Cowen
    3/19/2025Outperform → Perform
    Oppenheimer
    1/3/2025$60.00Peer Perform → Outperform
    Wolfe Research
    9/12/2024$42.00Equal Weight
    Wells Fargo
    8/27/2024$55.00Buy
    Redburn Atlantic
    More analyst ratings

    $CG
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Carlyle Secured Lending, Inc. Schedules Earnings Release and Quarterly Earnings Call to Discuss its Financial Results for the Fourth Quarter and Full Year Ended December 31, 2025

    NEW YORK, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Carlyle Secured Lending, Inc. ("Carlyle Secured Lending") (NASDAQ:CGBD) will host a conference call at 11:00 a.m. (Eastern Time) on Wednesday, February 25, 2026 to announce its financial results for the fourth quarter and full year ended December 31, 2025. The Company will report its quarterly financial results on Tuesday, February 24, 2026. The conference call will be available via public webcast via a link on Carlyle Secured Lending's website at carlylesecuredlending.com and will also be available on the website soon after the call's completion. About Carlyle Secured Lending, Inc.     Carlyle Secured Lending, Inc. is a publicly traded (NASDA

    1/27/26 4:05:00 PM ET
    $CG
    $CGBD
    Investment Managers
    Finance
    Finance: Consumer Services

    Resonetics to Acquire Resolution Medical, Expanding Capabilities in Neuromodulation and Structural Heart Markets

    NASHUA, N.H., Jan. 27, 2026 /PRNewswire/ -- Resonetics announced today that it has signed an agreement to acquire Resolution Medical, a leading provider of integrated design and manufacturing solutions for complex medical devices. Resolution Medical is headquartered in Fridley, MN, with additional operations in the Netherlands, and is currently owned by Arcline Investment Management. The transaction adds complementary capabilities in high-growth therapeutic markets, including neuromodulation, structural heart, and interventional cardiology to current Resonetics offerings. The

    1/27/26 2:00:00 PM ET
    $CG
    Investment Managers
    Finance

    Acentra Health Appoints Balajee Sethuraman as Executive Vice President and Chief Business Services Officer

    MCLEAN, Va., Jan. 27, 2026 (GLOBE NEWSWIRE) -- Acentra Health, a technology and health solutions company dedicated to accelerating better health outcomes for government and commercial clients and the populations they serve, today announced the appointment of Balajee Sethuraman as Executive Vice President and Chief Business Services Officer (CBSO), where he will lead the company's business services and delivery operations. This strategic addition to Acentra Health's executive leadership team supports its ongoing efforts to streamline and strengthen enterprise-wide delivery through a unified operating model. "Balajee is a transformative leader with exceptional experience scaling global team

    1/27/26 9:33:00 AM ET
    $CG
    Investment Managers
    Finance

    $CG
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Carlyle Group Inc. disposed of 111,994,953 shares and disposed of 55,557,381 units of Class B Common Stock (SEC Form 4)

    4 - Carlyle Group Inc. (0001527166) (Reporting)

    1/21/26 4:30:21 PM ET
    $CG
    Investment Managers
    Finance

    New insider Nedelman Jeffrey claimed ownership of 1,499,881 shares (SEC Form 3)

    3 - Carlyle Group Inc. (0001527166) (Issuer)

    1/9/26 5:07:52 PM ET
    $CG
    Investment Managers
    Finance

    New insider Jenkins Mark David claimed ownership of 1,414,484 shares (SEC Form 3)

    3 - Carlyle Group Inc. (0001527166) (Issuer)

    1/9/26 5:06:28 PM ET
    $CG
    Investment Managers
    Finance

    $CG
    SEC Filings

    View All

    The Carlyle Group Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Carlyle Group Inc. (0001527166) (Filer)

    12/5/25 4:10:33 PM ET
    $CG
    Investment Managers
    Finance

    SEC Form 13F-HR filed by The Carlyle Group Inc.

    13F-HR - Carlyle Group Inc. (0001527166) (Filer)

    11/7/25 4:37:43 PM ET
    $CG
    Investment Managers
    Finance

    SEC Form 10-Q filed by The Carlyle Group Inc.

    10-Q - Carlyle Group Inc. (0001527166) (Filer)

    11/7/25 4:11:15 PM ET
    $CG
    Investment Managers
    Finance

    $CG
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    UBS resumed coverage on Carlyle Group with a new price target

    UBS resumed coverage of Carlyle Group with a rating of Buy and set a new price target of $74.00

    12/11/25 9:06:22 AM ET
    $CG
    Investment Managers
    Finance

    BMO Capital Markets initiated coverage on Carlyle Group with a new price target

    BMO Capital Markets initiated coverage of Carlyle Group with a rating of Outperform and set a new price target of $74.00

    10/3/25 8:37:30 AM ET
    $CG
    Investment Managers
    Finance

    Carlyle Group upgraded by Citigroup with a new price target

    Citigroup upgraded Carlyle Group from Neutral to Buy and set a new price target of $65.00

    7/10/25 8:23:02 AM ET
    $CG
    Investment Managers
    Finance

    $CG
    Financials

    Live finance-specific insights

    View All

    Carlyle Secured Lending, Inc. Schedules Earnings Release and Quarterly Earnings Call to Discuss its Financial Results for the Fourth Quarter and Full Year Ended December 31, 2025

    NEW YORK, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Carlyle Secured Lending, Inc. ("Carlyle Secured Lending") (NASDAQ:CGBD) will host a conference call at 11:00 a.m. (Eastern Time) on Wednesday, February 25, 2026 to announce its financial results for the fourth quarter and full year ended December 31, 2025. The Company will report its quarterly financial results on Tuesday, February 24, 2026. The conference call will be available via public webcast via a link on Carlyle Secured Lending's website at carlylesecuredlending.com and will also be available on the website soon after the call's completion. About Carlyle Secured Lending, Inc.     Carlyle Secured Lending, Inc. is a publicly traded (NASDA

    1/27/26 4:05:00 PM ET
    $CG
    $CGBD
    Investment Managers
    Finance
    Finance: Consumer Services

    Carlyle Credit Income Fund Schedules First Quarter 2026 Financial Results and Investor Conference Call

    NEW YORK, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Carlyle Credit Income Fund ("we," "us," "our," "CCIF" or the "Fund") (NYSE:CCIF) announced today that it will release financial results after market close on Wednesday, February 25, 2026, for its first quarter of 2026. CCIF will host a conference call at 10:00 a.m. EST on Thursday, February 26, 2026, to discuss the results. The conference call will be available via public webcast via a link on Carlyle Credit Income Fund's website at www.carlylecreditincomefund.com and a replay will also be available on the website soon after the call's completion. About Carlyle Credit Income Fund Carlyle Credit Income Fund (NYSE:CCIF) is an externally managed

    1/22/26 4:10:00 PM ET
    $CCIF
    $CG
    Finance/Investors Services
    Finance
    Investment Managers

    Vantage Group Holdings to be acquired by Howard Hughes Holdings

    Vantage's Diversified Specialty Insurance Platform Delivers Lower Risk and Superior Return Potential HHH to Host a Conference Call and Presentation on Thursday, December 18 at 8:30 a.m. ET, With an X Spaces Session to Follow HAMILTON, Bermuda, Dec. 18, 2025 /PRNewswire/ -- Vantage Group Holdings Ltd. ("Vantage"), a privately held leading specialty insurance and reinsurance company backed by Carlyle and Hellman & Friedman today announced that it has entered into a definitive agreement for Howard Hughes Holdings Inc. (NYSE:HHH) ("Howard Hughes," "HHH," or the "Company") to acquire 100% of Vantage for $2.1 billion in cash or approximately 1.5x year-end 2025 book value. The transaction is expect

    12/18/25 6:12:00 AM ET
    $CG
    $HHH
    Investment Managers
    Finance
    Real Estate Investment Trusts
    Real Estate

    $CG
    Leadership Updates

    Live Leadership Updates

    View All

    Acentra Health Appoints Balajee Sethuraman as Executive Vice President and Chief Business Services Officer

    MCLEAN, Va., Jan. 27, 2026 (GLOBE NEWSWIRE) -- Acentra Health, a technology and health solutions company dedicated to accelerating better health outcomes for government and commercial clients and the populations they serve, today announced the appointment of Balajee Sethuraman as Executive Vice President and Chief Business Services Officer (CBSO), where he will lead the company's business services and delivery operations. This strategic addition to Acentra Health's executive leadership team supports its ongoing efforts to streamline and strengthen enterprise-wide delivery through a unified operating model. "Balajee is a transformative leader with exceptional experience scaling global team

    1/27/26 9:33:00 AM ET
    $CG
    Investment Managers
    Finance

    Acentra Health Appoints Deborah Ricci as Executive Vice President and Chief Financial Officer

    MCLEAN, Va., Jan. 14, 2026 (GLOBE NEWSWIRE) -- Acentra Health, a technology and health solutions company dedicated to accelerating better health outcomes for government and commercial clients and the populations they serve, today announced the appointment of Deborah Ricci as Executive Vice President and Chief Financial Officer (CFO). Ricci joins Acentra Health from Guidehouse Inc., where she most recently served as Partner and Chief Financial & Administrative Officer. In that role, she oversaw finance and accounting functions as well as quality, risk, security, and facilities, while supporting the firm's continued growth and operational transformation. Earlier in her career, Ricci held mu

    1/14/26 9:35:00 AM ET
    $CG
    Investment Managers
    Finance

    Abingworth Announces Leadership Transition and Appointments

    Kurt von Emster transitions role of Head of Abingworth Life Sciences to Dr. Bali Muralidhar Travis Wilson joins as Managing Director across Abingworth and Carlyle, focusing on clinical co-development and life sciences buyout opportunities Kurt remains a Managing Partner of Abingworth focusing on clinical co-development investments and supporting venture investments while advancing Abingworth's strategic vision for growth January 5, 2026 – Abingworth, a leading transatlantic life sciences investment firm and part of global investment firm Carlyle (NASDAQ:CG), today announced several leadership changes. Kurt von Emster, Managing Partner and Head of Abingworth Life Sciences, is transitioning

    1/5/26 4:00:00 AM ET
    $CG
    Investment Managers
    Finance

    $CG
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by The Carlyle Group Inc.

    SC 13D/A - Carlyle Group Inc. (0001527166) (Subject)

    11/15/24 5:22:29 PM ET
    $CG
    Investment Managers
    Finance

    Amendment: SEC Form SC 13D/A filed by The Carlyle Group Inc.

    SC 13D/A - Carlyle Group Inc. (0001527166) (Filed by)

    10/21/24 4:31:27 PM ET
    $CG
    Investment Managers
    Finance

    Amendment: SEC Form SC 13D/A filed by The Carlyle Group Inc.

    SC 13D/A - Carlyle Group Inc. (0001527166) (Filed by)

    10/15/24 4:31:27 PM ET
    $CG
    Investment Managers
    Finance